Paediatric and adult bronchiectasis: Vaccination in prevention and management

ABSTRACTBronchiectasis has received increased attention recently, including an emphasis on preventing infective exacerbations that are associated with disease progression and lung function decline. While there are several bacteria and viruses associated with bronchiectasis, licensed vaccines are only currently available forStreptococcus pneumoniae,Haemophilus influenzae (H. influenzae protein D as a conjugate in a pneumococcal vaccine),Mycobacterium tuberculosis, Bordetella pertussis and influenza virus. The evidence for the efficacy and effectiveness of these vaccines in both preventing and managing bronchiectasis in children and adults is limited with the focus of most research being on other chronic lung disorders, such as chronic obstructive pulmonary diseases, asthma and cystic fibrosis. We review the existing evidence for these vaccines in bronchiectasis and highlight the existing gaps in knowledge. High ‐quality experimental and non‐experimental studies using current state‐of‐the‐art microbiological methods and validated, standardised case definitions are needed across the depth and breadth of the vaccine development pathway.
Source: Respirology - Category: Respiratory Medicine Authors: Tags: Invited Review Series: Paediatric and Adult Bronchiectasis Source Type: research